| Authors: |
Vieira M; Sorbonne Universités AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Médecine Interne et Immunologie Clinique, F-75013, Centre National de Référence Maladies Autoimmunes Systémiques Rares, Centre National de Référence Maladies Autoinflammatoires et Amylose Inflammatoire (CEREMAIA), Inflammation-Immunopathology-Biotherapy Department (DMU 3iD), CIC Biotherapy, INSERM 959, Groupe Hospitalier Pitié-Salpetriere, AP-HP, Paris, France; Rheumatology Division, Department of Internal Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Ghayad E; Sorbonne Universités AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Médecine Interne et Immunologie Clinique, F-75013, Centre National de Référence Maladies Autoimmunes Systémiques Rares, Centre National de Référence Maladies Autoinflammatoires et Amylose Inflammatoire (CEREMAIA), Inflammation-Immunopathology-Biotherapy Department (DMU 3iD), CIC Biotherapy, INSERM 959, Groupe Hospitalier Pitié-Salpetriere, AP-HP, Paris, France., Aeschlimann FA; Department of Rheumatology, University Children's Hospital Basel UKBB, Basel, Switzerland., Peres Lima JP; Rheumatology Division, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil., Marvisi C; Division of Rheumatology, Azienda USL-IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Reggio Emilia, Italy., Iacomelli G; Department of Internal Medicine, ASST Fatebenefratelli-Sacco, Fatebenefratelli Hospital, 20121, Milan, Italy., Mekinian A; Department of Internal Medicine, Sorbonne Universités, AP-HP, Hôpital Saint-Antoine, Centre National de Référence Maladies Autoimmunes Systémiques Rares, Centre National de Référence Maladies Autoinflammatoires et Amylose Inflammatoire (CEREMAIA), Inflammation-Immunopathology-Biotherapy Department (DMU 3iD), Paris, France., Koné-Paut I; Department of Pediatric Rheumatology, National Referral Centre of Auto-Inflammatory Diseases and Inflammatory Amyloidosis, CEREMAIA, CHU de Bicêtre, APHP, University of Paris Saclay, Le Kremlin Bicêtre, France., Bader-Meunier B; Department of Pediatric Immunology, Hematology and Rheumatology, Necker Hospital, AP-HP, National Reference Centre for Rare Rheumatic and Autoimmune Systemic Diseases in Children, RAISE, France., Hassold N; Department of Pediatric Rheumatology, National Referral Centre of Auto-Inflammatory Diseases and Inflammatory Amyloidosis, CEREMAIA, CHU de Bicêtre, APHP, University of Paris Saclay, Le Kremlin Bicêtre, France., Comarmond C; Department of Internal Medicine and Clinical Immunology, Lariboisière Hospital, AP-HP, Paris, France., Lambert M; Univ. Lille, Inserm, CHU Lille, Department of Internal Medicine and Clinical Immunology, Hopital Claude Huriez, CERAINOM, U1286 - INFINITE - Institute for Translational Research in Inflammation, Lille, France., Mirault T; Université Paris Cité, National Reference Center for Rare Arterial diseases - CRMR MARS, FAVA-MULTI, VASCERN, Department of Vascular Medicine, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France., Benhamou Y; Department of Internal Medicine, CHU de Rouen, UniRouen, Rouen, France., Espitia O; Nantes Université, CHU Nantes Department of Internal and Vascular Medicine, CNRS UMR 6291, INSERM UMR 1087, l'institut du Thorax Team III Vascular and Pulmonary Diseases, F-44000, Nantes, France., Redheuil A; Sorbonne Université, INSERM 1146, CNRS 7371, Laboratoire d'Imagerie Biomédicale, Department of Cardiovascular Radiology, Pitié-Salpêtrière Hospital AP-HP, Paris, France., Gaudric J; Department of Vascular and Endovascular Surgery-Tertiary Aortic Center, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris and Sorbonne Médecine Universités, Paris, France., Chiche L; Department of Vascular and Endovascular Surgery-Tertiary Aortic Center, Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris and Sorbonne Médecine Universités, Paris, France., Cacoub P; Sorbonne Universités AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Médecine Interne et Immunologie Clinique, F-75013, Centre National de Référence Maladies Autoimmunes Systémiques Rares, Centre National de Référence Maladies Autoinflammatoires et Amylose Inflammatoire (CEREMAIA), Inflammation-Immunopathology-Biotherapy Department (DMU 3iD), CIC Biotherapy, INSERM 959, Groupe Hospitalier Pitié-Salpetriere, AP-HP, Paris, France., Kougkas N; Fourth Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Greece., Tombetti E; Department of Internal Medicine, ASST Fatebenefratelli-Sacco, Fatebenefratelli Hospital, 20121, Milan, Italy., Salvarani C; Division of Rheumatology, Azienda USL-IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Reggio Emilia, Italy., Silva de Souza AW; Rheumatology Division, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil., Misra DP; Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India., Chevret S; Biostatistics Department, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Cité, Paris, France., Saadoun D; Sorbonne Universités AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Médecine Interne et Immunologie Clinique, F-75013, Centre National de Référence Maladies Autoimmunes Systémiques Rares, Centre National de Référence Maladies Autoinflammatoires et Amylose Inflammatoire (CEREMAIA), Inflammation-Immunopathology-Biotherapy Department (DMU 3iD), CIC Biotherapy, INSERM 959, Groupe Hospitalier Pitié-Salpetriere, AP-HP, Paris, France. Electronic address: david.saadoun@aphp.fr. |
